The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback CNBC Katie Stockton breaks down the charts in Bristol-Myers, J&J and Pfizer. Bristol Johnson & Johnson (JNJ) Pfizer (PFE) Stockton 3 weeks
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever The Motley Fool 14 hours
Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for Growth Insider Monkey 19 hours
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? Investor's Business Daily 2 days
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough CNBC 3 days
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It Zacks 3 days
Is Johnson & Johnson (JNJ) the Best Blue Chip Stock To Invest In According to Short Sellers? Insider Monkey 4 days
Pfizer says drug for deadly cancer condition that causes weight loss shows positive trial data CNBC 5 days
The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly The Wall Street Journal 7 days
Katie Stockton on when investors should start worrying about the yield curve recession signal CNBC 1 week
Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged Seeking Alpha 1 week
Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade) Seeking Alpha 2 weeks
Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025 Seeking Alpha 2 weeks
Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript) Seeking Alpha 2 weeks
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks 2 weeks
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now? Insider Monkey 2 weeks
Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks